We present a review of the association between COVID-19 and autoimmune diseases,
focusing on similarities in immune responses, cross-reactivity of SARS-CoV-2, the …

Background As a major virus outbreak in the 21st century, the Coronavirus disease 2019
(COVID-19) pandemic has led to unprecedented hazards to mental health globally. While …

Abstract Angiotensin‐converting enzyme 2 (ACE2) has been established as the functional
host receptor for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus …

The severity and outcome of coronavirus disease 2019 (COVID-19) largely depends on a
patient's age. Adults over 65 years of age represent 80% of hospitalizations and have a 23 …

Coronavirus disease 2019 (COVID-19), due to the severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), has become an epidemiological threat and a worldwide …

Coronavirus disease 2019 (COVID-19) represents a public health crisis of pandemic
proportions. Caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV …

The severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) that has caused the
coronavirus disease 2019 (COVID‐19) pandemic represents the greatest international …

Owing to the limitations of the present efforts on drug discovery against severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) and the lack of the understanding of the …

Abstract Glucose 6-phosphate dehydrogenase (G6PD) deficiency facilitates human
coronavirus infection due to glutathione depletion. G6PD deficiency may especially …

In December 2019, a novel coronavirus, named Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2) or (2019-nCoV) with unknown origin spread in Hubei province …